* Sabra Health Care REIT Inc SBRA.OQ SBRA.O is expected
to show a fall in quarterly revenue when it reports results on
May 3.
* The Irvine California-based company is expected to report
a
2.5% decrease in revenue to $159.1 million from $163.11 million
a year ago, according to the mean estimate from 7 analysts,
based on Refinitiv data.
* Refinitiv's mean analyst estimate for Sabra Health Care
REIT
Inc is for earnings of 11 cents per share.
* The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 5 "strong buy" or "buy," 9
"hold" and 2 "sell" or "strong sell."
* The mean earnings estimate of analysts had risen by
about 0.1%
in the last three months.
* Wall Street's median 12-month price target for Sabra
Health Care
REIT Inc is $13, above its last closing price of $11.36.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Dec. 31 2022 0.35 0.36 0.37 Beat 4.1
Sep. 30 2022 0.37 0.37 0.36 Missed -3.2
Jun. 30 2022 0.38 0.38 0.39 Beat 3.6
Mar. 31 2022 0.38 0.38 0.38 Met -0.7
Dec. 0.36 0.37 0.39 Beat 5.7
31 2021
Sep. 30 2021 0.39 0.39 0.38 Missed -2.2
Jun. 30 2021 0.39 0.39 0.39 Met -1.2
Mar. 31 2021 0.40 0.40 0.40 Met -0.4
This summary was machine generated May 2 at 02:21 GMT. All
figures in US dollars unless otherwise stated